Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Familial ependymoma × Tamoxifen × Clear all

Sponsor

Conditions

Breast Neoplasms 69 Carcinoma, Intraductal, Noninfiltrating 9 Breast Carcinoma In Situ 6 Breast Neoplasms, Male 5 Neoplasms 3 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Inflammatory Breast Neoplasms 2 Sleep Wake Disorders 1 Risk Reduction Behavior 1 Obesity 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Mastodynia 1 Glioma 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Desmoid Tumors 1 Cystic Fibrosis 1 Cystadenocarcinoma, Serous 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Arthralgia 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 ribociclib 1 palbociclib 1 olaparib 1 etoposide phosphate 1 erdafitinib 1 X-Rays 1 Sunitinib 1 Specimen Handling 1 Radiotherapy 1 Phantoms, Imaging 1 Nuclear Medicine Department, Hospital 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Microarray Analysis 1 Lapatinib 1 Irinotecan 1 Immunologic Techniques 1 Immunohistochemistry 1 Immunoglobulin G 1 Ifosfamide 1 Fluorodeoxyglucose F18 1 Etoposide 1 Donepezil 1 Disulfides 1 Dasatinib 1 Cyproheptadine 1 Carboplatin 1 Blotting, Western 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡